EUVIMED · CrossrefJournal
Archiv der Pharmazie
ISSN 0365-6233 · Wiley
Latest articles
Effective Cross‐Coupling Synthesis of Novel Ethynyl‐Decorated Benzo[ b ][1,6]naphthyridines and Their Evaluation as Inhibitors of Cholinesterases and Monoamine Oxidases
Indazole Derivatives as Emerging Scaffolds for Anti‐Breast Cancer Therapy: Synthesis, Structure–Activity Relationship, and Therapeutic Potential
Towards Greener Pastures in Alzheimer's Therapy: Synthesis and XRD/HSA/DFT Mechanistic Investigation of Novel Trifluoromethylated Compounds
Exploring Key Microbial Enzymes as Targets for Benzimidazole Derivatives: Synthesis, SAR, and Therapeutic Relevance
Ataxia Telangiectasia and Rad3‐Related Kinase as a Drug Target and Its Inhibitors: Synthetic Aspects, Current Research and Potential Perspectives
Issue Information: Arch Pharm (11/2026)
Recent Developments in Sulfonafmide‐Based Anti‐Malarial Agents: Structure–Activity Relationships and Future Perspectives
Discovery of Benzothiazinone and Quinazolinedione Carboxamides as Low‐Nanomolar Soluble Epoxide Hydrolase Inhibitors
Roflumilast and Melatonin Alleviate Acetic Acid‐Induced Ulcerative Colitis via Modulating AMPK/mTOR Signaling, Autophagy‐Related Markers, Intestinal Epithelial Barrier, and NLRP3 Inflammasome
Metabolic Activation‐Dependent Anti‐Liver Cancer Activity and Organ‐Specific Toxicity of Retrorsine From Fanhuncao ( Jacobaea cannabifolia and J. litvinovii )
Discovery of VEGFR‐2 Inhibitors From Leonurus japonicus via Integrated Genetic Authentication, Molecular Networking, and In Silico Analysis
Targeting Human Protein Kinase CK2 by a Library of Indeno[1,2‐ b ]Indoles: Contribution of Thermal Shift Assay to Pre‐Screening and Co‐Crystallization to Post‐Screening
Cellular and Molecular Mechanisms of Berberine in Cancer Therapy: Recent Advances
Synthesis and Characterization of Tritium‐Labeled Neuropeptide Y Y 5 Receptor Ligands Derived From CGP71683A
Design, Synthesis, and Biological Evaluation of Biphenylsulfonyl Indole‐Based Thiosemicarbazones as Potential AChE and CA I‐II Inhibitors
Issue Information: Arch Pharm (8/2026)
Breaking the Myb–KIX Alliance: Structure‐Guided Discovery of Biaryl Hydroxy‐Naphthamides as Disruptors of the c‐Myb–CBP/p300 KIX Protein–Protein Interaction
Olikomycin A Disrupts Gram‐Positive Bacterial Membranes Through Calcium‐Dependent Binding to Phosphatidylglycerol
Structural Modifications of Nonsteroidal Anti‐Inflammatory Drugs (NSAIDs): New Horizons in Antimicrobial Drug Discovery
Venom‐Derived Peptides in Breast Cancer: Pharmacological Mechanisms and Medicinal Chemistry‐Guided Translational Development
Benzophenone Derivatives as a New Class of Anti‐Infectives Against Acanthamoeba spp
Recent Developments and Structure–Activity Relationships of BRAF Inhibitors for Cancer Drug Discovery
First UV‐Based Strategies Integrating Whiteness, Greenness, and Blueness Appraisals for Estimating Meloxicam and Tramadol Concurrently in Their Veterinary Mixture
Mutation‐Induced Pocket Deactivation: How Ser353/Pro245 Alters K Ca 2.2 vs. K Ca 3.1 Ligand Selectivity
Recent Overview on the Molecular Hybrids Integrated With Benzosuberone/Benzo[7]annulene Derivatives as Multi‐Target Therapeutics
Gastroprotective Activity of Myrtenol Derivatives Obtained by Biocatalytic Esterification and Photooxidation
Total Synthesis of Marine Natural Product Sunshinamide via Macrolactonization
Emerging Indole and Azaindole Hybrid Agents for Leukemia Therapy: Recent Research Advances and Therapeutic Potential
Thiazole‐Derived Dual EGFR/CDK‐2 Inhibitors: Rational Design, Synthesis, In Vitro Anticancer Evaluation, Mechanistic Profiling, and Computational Binding Analysis
Issue Information: Arch Pharm (7/2026)
Volumes
2026 · 2032025 · 2812024 · 2622023 · 1832022 · 1782021 · 1692020 · 1412019 · 1142018 · 1122017 · 1042016 · 1232015 · 1222014 · 1342013 · 1152012 · 1202011 · 1032010 · 812009 · 882008 · 1732007 · 912006 · 982005 · 882004 · 912003 · 722002 · 642001 · 862000 · 1061999 · 1081998 · 1041997 · 811996 · 951995 · 1631994 · 1661993 · 1641992 · 1671991 · 1931990 · 1681989 · 1721988 · 2301987 · 230
EUVIMED